- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01093339
To Determine if Sleep Deprivation Results in Increased Esophageal Acid Exposure (IRUSESOM0428)
August 18, 2010 updated by: Southern Arizona VA Health Care System
To Determine if Sleep Deprivation Results in Increased Esophageal Acid Exposure, and if This Effect is Mediated in Gastroesophageal Reflux Disease (GERD)Patients by Altering Appetite Regulation
The purpose of this study is to determine if sleep deprivation results in increased esophageal acid exposure in healthy controls and gastroesophageal reflux disease (GERD) patients.
Study Overview
Status
Completed
Conditions
Detailed Description
To determine if increased esophageal acid exposure is mediated by altering appetite regulation.
To assess if there is any relationship between sleep deprivation and the serum level of TNF-alfa (a protein that can be elevated in inflammation).
Study Type
Observational
Enrollment (Actual)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85723
- SArizonaVAHCS
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
25 subjects w/ GERD 25 subjects w/o GERD
Description
Inclusion Criteria:
- Male/Female - 18-80
- 2 or more episodes of heartburn a week for last 3 months
Exclusion Criteria:
- Previous upper GI surgery
- Underlying co-morbidity
- Narcotic medications
- Psychotropic's and Benzodiazapines medications
- Hx of psychological abnormalities
- Hx of ETOH in previous 6 mos.
- Diabetes Mellitus
- Neuropathy
- Seizures
- Sleep Apnea
- Co-morbidity that interfere w/sleep
- Women who are pregnant, or childbearing yrs, not on BC
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
No treatment
Subjects w/ condition and subjects w/o condition of GERD (gastroesophageal reflux disease)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ronnie Fass, MD, SArizona VAHCS
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2006
Primary Completion (Actual)
March 1, 2010
Study Completion (Actual)
March 1, 2010
Study Registration Dates
First Submitted
March 24, 2010
First Submitted That Met QC Criteria
March 24, 2010
First Posted (Estimate)
March 25, 2010
Study Record Updates
Last Update Posted (Estimate)
August 19, 2010
Last Update Submitted That Met QC Criteria
August 18, 2010
Last Verified
August 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SLEEP DEPRIVATION
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastroesophageal Disease
-
Medical College of WisconsinNot yet recruitingGastroesophageal Reflux Disease | Refractory Gastroesophageal Reflux DiseaseUnited States
-
Ying ZhuNot yet recruitingGastroesophageal Reflux Disease (GERD)China
-
Daewon Pharmaceutical Co., Ltd.CompletedGERD (Gastroesophageal Reflux Disease)South Korea
-
Ezisurg Medical Co. Ltd.University Hospital, MontpellierCompletedGastroesophageal Reflux Disease (GERD)France
-
I.M. Sechenov First Moscow State Medical UniversityActive, not recruitingGastroesophageal Reflux Disease (GERD) | Non-Erosive Gastro-Esophageal Reflux DiseaseRussia
-
Onconic Therapeutics Inc.Not yet recruitingNon-erosive Gastroesophageal Reflux Disease
-
GlaxoSmithKlineCompletedReflux, Gastroesophageal | Gastroesophageal Reflux DiseaseAustralia
-
Cinclus Pharma Holding ABWithdrawn
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruiting
-
Mansoura UniversityWithdrawnGastroesophageal Reflux Disease